Fast Fit Keto was used and this is in contrast to the coop trial that showed significant benefit in terms of production and hospitalizations and also showed mortality reduction with the edge to edge repair and these two trials helped us understand that patient selection is key when you're dealing with secondary mitral regurgitation if you look at the inclusion criteria of the mitra fr versus the co-act the inclusion criteria for mitra fr included patients with effective regurgitant artifice areas of more than 20 millimeters squared or regurgitant volume more than 30 cc in contrast the co-act used the severe functional mitral regurgitation criteria except by the us guidelines where the effective regurgitant artifice area was more than 30 millimeters squared or the regurgitant volume was 45 cc's if you looked up if you look at the population the population that was enrolled was also significantly different in that the effective regurgitating artifice area was larger in the cohort and the lv and diastolic volume was smaller so more severe mr with smaller ventricles and that kind of gave us to this new concept of proportionate or disproportionate mr the way to look at it is that proportionate mmr basically means that there's a linear relationship between the lv and diastolic volume and the effective regurgitant artifice for any given ef so if you have
https://infosupplement.com/fast-fit-keto-reviews
https://infosupplement.com/fast-fit-keto-reviews